Fouad Namouni, Director at Aprea Therapeutics, holds 69.07K shares in Blueprint Medicines (Ticker: BPMC), holds 4.61K shares in Aprea Therapeutics (Ticker: APRE), holds ― shares in Vor Biopharma (Ticker: VOR). Most recently, Fouad Namouni Sold ― shares of Blueprint Medicines on Oct 04, 2024 for an estimated value of 324.50K.
What is the percentage of profitable transactions made by Fouad Namouni?
The percentage of profitable transactions made by Fouad Namouni is 43%.
What is the average return per transaction made by Fouad Namouni?
The average return per transaction made by Fouad Namouni is -18.70%.
What stocks does Fouad Namouni hold?
Fouad Namouni holds: APRE, BPMC, VOR stocks.
What was Fouad Namouni’s latest transaction?
Fouad Namouni latest transaction was an Informative Sell of $324.50K.
What was Fouad Namouni's most profitable transaction?
Fouad Namouni’s most profitable transaction was an Informative Sell of BPMC stock on October 7, 2021. The return on the trade was 40.10%.
What is Fouad Namouni's role in Aprea Therapeutics?
Fouad Namouni's role in Aprea Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.